Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated from v3.4.0 to v3.4.1 in the page header, indicating a backend/template change. No substantive study content, eligibility criteria, or results are affected by this update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check22 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check51 days agoChange DetectedLocations section reorganized; a unified 'Locations' header was added and state-level site entries updated (Arizona, California, Colorado, Kentucky, Michigan, Minnesota, Nebraska, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Virginia, Wisconsin).SummaryDifference1%

- Check72 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.2, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedThe notice about government funding and NIH Clinical Center operating status was removed, a non-significant site-wide change; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check102 days agoChange DetectedNo core study content changes are evident; the screenshots show only minor UI/layout differences on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.